November 14, 2007 (Press Release) - GlaxoSmithKline announced today that it is implementing changes to the US product label for Avandia (rosiglitazo...
The US Food and Drug Administration (FDA) announced Aug 14 that manufacturers of thiazolidinediones, commonly prescribed for the treatment of Type 2 d...
Companies Will Include Boxed Warning on Drug LabelAugust 15, 2007 (FDA) - The U.S. Food and Drug Administration today announced manufacturers of certa...
Filed under: Type 2, Drugs, Daily NewsAccording to a new Associated Press (AP) feature, federal regulators have experienced a dramatic surge in report...
Filed under: Type 2, Adult Onset, DrugsIt has only been ten days since the the first lawsuit was filed on behalf of investors against Avandia manufact...
Filed under: Drugs, Daily newsIn a scary bit of news that affects more than 6 million Americans, a drug commonly used to treat diabetes has been linke...
Avandia sales have been a bright spot for GlaxoSmithKline, with the diabetes pill bringing in revenue of $3.25 billion world-wide last year. But the ...